UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,713,835 | +10030.4% | 2,620,545 | +6581.3% | 6.69% | +9318.3% |
| Q1 2023 | $362,411 | -92.7% | 39,222 | -93.0% | 0.07% | -92.7% |
| Q4 2022 | $4,967,200 | -31.6% | 560,000 | -35.9% | 0.97% | -44.3% |
| Q3 2022 | $7,267,000 | +1.6% | 873,424 | 0.0% | 1.75% | +2.0% |
| Q2 2022 | $7,153,000 | -6.0% | 873,424 | 0.0% | 1.72% | -6.7% |
| Q1 2022 | $7,608,000 | -8.4% | 873,424 | 0.0% | 1.84% | -0.3% |
| Q4 2021 | $8,306,000 | -34.2% | 873,424 | +16.5% | 1.84% | -37.2% |
| Q3 2021 | $12,615,000 | – | 750,000 | – | 2.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |